drugset / Trial / NCT06820424
Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with CDH17-positive Advanced Solid Tumors
Phase 0
Recruiting
30 enrolled
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
Guangzhou Bio-gene Technology Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, open-label, single-arm study to evaluate the safety and preliminary efficacy of anti-CDH17 CAR-T cells in patients with CDH17-positive advanced solid tumors.
Timeline
- Start
- 2025-03
- Primary completion
- 2028-01
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-CDH17 CAR-T cells | Cell therapy | — | Intravenous |
Indications
No indication recorded.